Choubey PK, Tripathi A, Tripathi MK, Seth A, Shrivastava SK (2021) <br />Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease<br /><i>Bioorg Chem</i> <b>111</b>: 104922<br /><br />Choubey PK, Tripathi A, Sharma P, Shrivastava SK (2020) <br />Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease<br /><i>Bioorganic & Medicinal Chemistry</i> <b>28</b>: 115721<br /><br />Tripathi A, Choubey PK, Sharma P, Seth A, Tripathi PN, Tripathi MK, Prajapati SK, Krishnamurthy S, Shrivastava SK (2019) <br />Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease<br /><i>Eur Journal of Medicinal Chemistry</i> <b>183</b>: 111707<br /><br />Tripathi A, Choubey PK, Sharma P, Seth A, Saraf P, Shrivastava SK (2019) <br />Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease<br /><i>Bioorg Chem</i> <b>95</b>: 103506<br /><br />Shrivastava SK, Sinha SK, Srivastava P, Tripathi PN, Sharma P, Tripathi MK, Tripathi A, Choubey PK, Waiker DK, Aggarwal LM, Dixit M, Kheruka SC, Gambhir S, Shankar S, Srivastava RK (2018) <br />Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease<br /><i>Bioorg Chem</i> <b>82</b>: 211<br /><br />